Eyenable® intraocular lenses

Eyenable® intraocular lenses

Hydrophobic acrylic monofocal IOL

High quality, high performance

Eyenable acrylate monofocal IOLs offer proven high optical and biological performance

  • Single focus intraocular lenses
  • Clear vision at one point of focus
  • High optical performance

Proven in millions of successful procedures

Hydrophobic acrylate intraocular lenses

Eyenable IOLs are made of hydrophobic acrylate material containing ultraviolet absorber.
This acrylic copolymer is a safe biomaterial with excellent optical properties.

Proven in millions of successful procedures

Hydrophobic acrylate intraocular lenses

Eyenable IOLs are made of hydrophobic acrylate material containing ultraviolet absorber.
This acrylic copolymer is a safe biomaterial with excellent optical properties.

Specifications

Optical type

Asymmetric biconvex optical surface

Material

Acrylic copolymer

Intraocular lens power range

+10.0 D to +30.0 D, every 0.5 D interval

Refractive index

1.55


Core diameter

6.0 mm

Total diameter

13.0 mm

Loop angle

Eyenable

Hydrophobic acrylic aspheric IOL

Contact us to orderInstructions for use

Eyenable

Hydrophobic acrylic toric IOL

Contact us to orderInstructions for use

Cross linked polyolefin series

交联聚烯烃系列

眼得乐人工晶状体


Products

Visionary clarity
Next-generation IOL made from
our globally patented cross-linked Polyisobutylene (xPIB)

Eyedeal is committed to helping cataract patients around the world regain their sight

Eyenable foldable intraocular lenses

Eyenable foldable intraocular lenses are made of conventional hydrophobic acrylate materials. Eyedeal has mastered the R&D and production of the whole process, from material synthesis and product design to process manufacturing, to provide patients with affordable good performance, high-quality IOLs.

Product details
Eyedeal
Next-generation xPIB IOL

Processed by cross-linked polyisobutylene (xPIB) material.

The Eyedeal series are the world’s latest generation of intraocular lenses. They are made of cross-linked polyisobutylene (xPIB) material. Global experts believe that cross-linked polyisobutylene intraocular lenses have better biocompatibility and stability, as well as excellent optical and mechanical properties. They require only a micro-incision while achieving a large optical surface, and reduce glare (positive and negative dysphotopsia) to provide patients with better intraocular lenses over the long-term.

Eyedeal has a global patent for cross-linked polyisobutylen (xPIB) material technology. This ends China’s reliance on importing high-end medical polymer materials and contributes to the goal of made-in-China products leading the world.

Orthokeratology

Eyedeal – paying attention to young people’s eye health

Orthokeratology (OK lens) is a rigid contact lens designed with rigid oxygen-permeable materials, which can reverse myopia or slow down the progression of myopia to a certain extent by temporarily changing the corneal shape.

In the “Guidelines for the Prevention and Treatment of Myopia” issued by the National Health and Medical Commission in 2018, orthokeratology lenses are listed as one of the effective methods for the prevention and control of myopia.

Eyedeal develops and designs a new orthokeratology lens

We have synthesized a highly biocompatible material with high oxygen permeability and low wetting angle. Its unique segmented optical design is more in line with the characteristics of the Asian eye and is more comfortable. The new precision machining process produces higher quality products.

Phakic intraocular lenses

Eyedeal ICL – see the wonderful world

Globally, phakic intraocular lenses (Phakic ICL) are widely recognized as an effective option for translating high refractive errors.

Eyedeal uses a new generation of ICLs designed and developed with globally patented cross linked polyisobutylene polymer materials, which have excellent performance and reduce the occurrence of adverse reactions, mainly helping customers with high myopia.

Glaucoma drainage tube

New treatment options for glaucoma patients

Glaucoma is the second leading cause of blindness in the world after cataracts, but the first irreversible cause of blindness.

Treatment of glaucoma

Glaucoma is mainly treated by reducing intraocular pressure to avoid optic nerve damage, or preventing optic nerve damage from continuing to develop.

Minimally invasive glaucoma surgery (MIGS) and glaucoma drainage tube implantation is a relatively simple procedure with few complications with low impact on patient quality of life. It is one of the best treatments for glaucoma.

Eyedeal pioneers and innovates in the field of glaucoma drainage tubes

Eyedeal’s team of ophthalmologists relies on unique material advantages and rich industry experience to develop the first domestic glaucoma drainage tube with independent intellectual property rights. With better biological safety and biological stability, it solves the problems of current drainage tube products

Medical polymer materials

Global patent, broad platform

Eyedeal has cooperated with Dr Leonard Pinchuk, Member of the American Academy of Engineering and recipient of the 2019 Russ Prize, to develop a new medical material – cross-linked polyisobutylene (xPIB).

Crosslinked polyisobutylene (crosslinked polyisobutylene-[CH2-C(CH3)2]n, xPIB) is synthesized from branched olefins and vinyl comonomers through high-temperature chemical cross-linking, which has been proven to have excellent clinical efficacy and biocompatibility.

Advantages of crosslinked polyisobutylene

Homogeneous homopolymer / No hydrolyzable groups / No degradation by-products / Alternating quaternary carbons in the main chain

Eyedeal has independent intellectual property rights and global patents for crosslinked polyisobutylene materials. We focus on other potential application scenarios and explore the infinite possibilities of crosslinked polyisobutylene.

As one of the few medical implantable materials with source innovation and complete intellectual property rights in China, cross-linked polyolefins also have very high value in orthopedics, neurosurgery, thoracic surgery and other fields.

Eyedeal regards R&D and innovation as fundamental. Our scientists and engineers focus on unmet clinical needs, actively expand scientific boundaries, develop new medical materials, and develop more extensive and in-depth product lines.


Core team

More than 20 from the global top 500 companies
Top industry experts

Guo Guangxu, MBA

Company founder
Chief Executive Officer and Chairman

Yang Zhou, Ph.D.

Founding Partner
Chief Technology Officer

Yang Yin

Founding Partner
Senior Vice President

Peng Qun, MD

Chief Medical Officer

Teresa Tan, American CPA

Chief Financial Officer

Ye Ming, Ph.D.

Vice President

Yan Dengzhu

Vice President

He Tao

Vice President


Scientific advisory board

World's leading ophthalmology researchers, scientists and technicians

Prof. Joseph p. Kennedy

Honorary Scientific Advisor

Dr. Len Pinchuk

Chair

Dr. Buddy Ratner

Member

Dr. Robert Ward

Member

Prof. Gerd Auffarth

Member

Dr. John Berdahl

Member

Dr. Sun Xing Huai

Member